Blog

Survey Reveals Site Perspectives on Clinical Trial Services

Posted by Elizabeth Gargill on Tue, Dec 1, 2020

What do doctors and nurses think about solutions designed to make clinical trials easier to conduct? Are they helpful? Do they alleviate burdens? And which ones do they prefer?

In this special Pharma15 Live! segment, BBK Worldwide industry experts Matt Kibby and Aaron Fleishman discuss recent Study Voices survey results that shed light on this topic. They examine doctor and nurse perspectives on services designed to provide support in conducting clinical trials — including services for virtual, hybrid, and decentralized clinical trials.

“We were looking at whether or not doctors and nurses at sites that were conducting clinical trials would appreciate different types of services that assist with their ability to conduct them."

-Matt Kibby, Principal, President, BBK Worldwide

Read More

Topics: Clinical Trials, Pharma15 Live!, Most Viewed, Study Voices, COVID-19, Matt Kibby, Aaron Fleishman, Decentralized Trials, Study Voices 2020, Hybrid Trials

Clinical Trial Innovation: More Important Now Than Ever

Posted by Elizabeth Gargill on Thu, Nov 19, 2020

 

Clinical Trial Innovation: More Important Now Than Ever

A new survey gives voice to the healthcare consumer in the wake of COVID-19 and highlights the importance of innovation in clinical trial patient enrollment and engagement.

DOWNLOAD NOW

New data provides clinical trial sponsors with the information they need to confidently embrace innovative solutions in response to COVID-19. The Study Voices 2020* survey reflects perspectives from patients, medical professionals, and members of the pharmaceutical industry. The findings reveal shifts in attitudes and behaviors since the onset of COVID-19 – insight that clinical trial sponsors can leverage for enrollment and engagement efforts, including for hybrid and virtual study models.

Read More

Topics: Patient Engagement, Patient Experience, Healthcare Consumer, COVID-19, International Clinical Trials, Patient Voice, Telehealth, Elizabeth Gargill, Study Voices 2020, Surveys, Site Voice, Publications

In a new Outsourcing-Pharma interview, Elizabeth Gargill discusses why clinical trial innovation matters more now than ever

Posted by BBK Worldwide on Fri, Oct 23, 2020

 

Earlier this week, Elizabeth Gargill went one-on-one with Outsourcing-Pharma, discussing findings from BBK's recent Study Voices survey that reveal shifts in healthcare consumer attitudes and behaviors since the onset of COVID-19. In this in-depth interview, Elizabeth discusses why clinical trial innovation is more important now than ever before and how clinical trial sponsors can leverage the survey findings to enhance their enrollment and engagement efforts.

Read More

Topics: Patient Engagement, Clinical Trials, Study Voices, Healthcare Consumer, Survey, Clinical Trial Innovations, Clinical Trial Enrollment, Study-life Balance, Outsourcing-Pharma, Telehealth

Why It’s Now Easier than Ever to Engage with Patients Wherever They Are

Posted by Elizabeth Gargill on Thu, Oct 15, 2020

 

Clinical trial sponsors now have access to several new solutions that make it possible to engage with patients wherever they are now more important than ever before as trials shift to hybrid and decentralized models.

Sponsors can transform their clinical trials with engagement solutions that prioritize patient care and convenience, helping maintain study momentum during COVID-19 and beyond.

Read More

Topics: Apps, Patient Experience, Study Voices, Patient Reimbursement, Patient Portals, Clinical Trial Innovations, COVID-19, Medication Delivery, In-home Nurse Visits

Ready, Set, Go Virtual!

Posted by Elizabeth Gargill on Tue, Oct 6, 2020

 

Ready, Set, Go Virtual!

New virtual engagement solutions are delivering patients the convenience and immediacy they want in their healthcare experience. Solutions that support decentralized or hybrid trials, like BBK’s virtual RSG® Card, are helping to remove some of the barriers to clinical trial participation that patients cite as the most challenging.

As a matter of fact, in BBK's recent Study Voices 2020 survey, patients selected "immediate reimbursement for study-related expenses" as the most important solution influencing their decision to participate in a clinical trial.

Read More

Topics: Patient Engagement, Patient Experience, Study Voices, Patient Reimbursement, RSG Card, Clinical Trial Innovations, Decentralized Trials, Virtual, Stipends

Study Voices 2020: Survey Findings Vol. 1

Posted by Elizabeth Gargill on Tue, Sep 29, 2020

 

During the last two weeks of August we surveyed more than 1,200 healthcare consumers, medical professionals, and members of the pharmaceutical industry for their perspectives on topics impacting today's healthcare consumer.

The findings provide a unique look at current attitudes and behaviors that inform the patient experience. They provide clinical trial sponsors with a snapshot of a critical moment in time when we're seeing the rise of telehealth, the adoption of decentralized and hybrid trials, and heightened awareness of clinical research. They also reveal new opportunities and challenges ahead for clinical trial enrollment and engagement.

Download Now

Read More

Topics: Patient Experience, Study Voices, Healthcare Consumer, Survey, Clinical Trial Innovations, COVID-19, Telehealth

BBK Worldwide Showcases Its Commitment to Innovation at DPharm 2020

Posted by Aaron Fleishman on Fri, Sep 18, 2020

 

DPharm. It's one of my favorite conferences that I look forward to each year. This year we will be virtual September 22-23, but still the same great energy and excitement. DPharm is a standout event that challenges and reports on innovation, with the goal of shaking up the way we conduct clinical trials so that we can reduce patient / physician burden and create greater efficiencies.

Read More

Topics: Disruptive Innovation, Conferences, Patient Experience, Study Voices, 2020 Events, Clinical Trial Innovations, COVID-19, DPHARM

Brand-aids for Clinical Trial Engagement

Posted by Danielle Frate, Art Director on Tue, Sep 15, 2020

 

While the public’s awareness of clinical studies as avenues to receive the latest potential treatments, contribute to medical science, and benefit from added care and attention grows, the need to ensure that patients are aware of study opportunities is crucial. Clinical teams are no longer simply referring to their study based on its protocol title or number, but instead selecting a consumer-facing name accompanied by a logo or icon to identify it within the marketplace.

But a brand is more than just a logo – it’s a means to create a first impression with a desired audience. Gone are the days when brands were reserved for consumer products. The earlier you are able to establish a brand for your study, the greater the chance you will achieve positive recognition throughout all phases - and perhaps even set the stage for post-approval marketing.

Read More

Topics: Patient Engagement, Advertising, Creative, Branding

Jessica Kim Named to PharmaVOICE 100 for Her Leadership and Expertise

Posted by Elizabeth Gargill on Tue, Sep 1, 2020

 

BBK Worldwide is honored to announce that our Creative Director for Patient Experience and Engagement, Jessica Kim, has been named to the 2020 PharmaVOICE 100 list of the most inspiring people in the life sciences industry as a patient champion. The award recognizes Ms. Kim for how she inspires and motivates those around her, her influence as a corporate leader, and her positive impact on the industry through her actions.

Read More

Topics: Patient Engagement, Patient Enrollment, Study-life Balance, PharmaVOICE, Jessica Kim, PharmaVOICE 100

Rob Laurens Discusses Navigating Patient Travel During COVID-19 with Outsourcing-Pharma

Posted by Elizabeth Gargill on Wed, Aug 19, 2020

 

Earlier this week, Principal of RSG Services Rob Laurens went one-on-one with Outsourcing-Pharma to discuss challenges associated with patient travel as COVID-19 restrictions ease.

In this in-depth interview, Rob addresses the importance of contingency planning, lessons learned, and the long-term impact of COVID-19 on patient travel. He also provides insight into services and resources that clinical trial sponsors can leverage to maximize patient safety and engagement during COVID-19 and beyond. Click here to read the full article.

Read More

Topics: Patient Travel, Patient Travel Programs, RSG Arrive, COVID-19, Rob Laurens, RSG Services, Outsourcing-Pharma